Cytek Biosciences Announces Executive and Board Changes
Ticker: CTKB · Form: 8-K · Filed: Sep 12, 2024 · CIK: 1831915
| Field | Detail |
|---|---|
| Company | Cytek Biosciences, Inc. (CTKB) |
| Form Type | 8-K |
| Filed Date | Sep 12, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, board-change, personnel
TL;DR
Cytek Biosciences shakes up leadership: new CSO appointed, board member added.
AI Summary
Cytek Biosciences, Inc. announced on September 9, 2024, changes in its executive team and board of directors. Specifically, Dr. John W. King has been appointed as the new Chief Scientific Officer, and Ms. Sarah E. Empey has joined the Board of Directors. These appointments are effective immediately and are part of the company's ongoing strategic initiatives.
Why It Matters
Changes in key leadership roles like Chief Scientific Officer and board composition can signal shifts in strategic direction, research focus, or governance for Cytek Biosciences.
Risk Assessment
Risk Level: medium — Changes in executive and board positions can introduce uncertainty regarding future strategy and operational execution.
Key Players & Entities
- Cytek Biosciences, Inc. (company) — Registrant
- Dr. John W. King (person) — Appointed Chief Scientific Officer
- Ms. Sarah E. Empey (person) — Appointed to Board of Directors
- September 9, 2024 (date) — Effective date of changes
FAQ
Who has been appointed as the new Chief Scientific Officer at Cytek Biosciences?
Dr. John W. King has been appointed as the new Chief Scientific Officer.
Who has joined the Board of Directors at Cytek Biosciences?
Ms. Sarah E. Empey has joined the Board of Directors.
What is the effective date of these appointments?
The appointments are effective as of September 9, 2024.
What is the primary business of Cytek Biosciences, Inc.?
Cytek Biosciences, Inc. is involved in the Laboratory Analytical Instruments industry, SIC code 3826.
In which state is Cytek Biosciences, Inc. incorporated?
Cytek Biosciences, Inc. is incorporated in Delaware.
Filing Stats: 404 words · 2 min read · ~1 pages · Grade level 12.1 · Accepted 2024-09-12 06:04:54
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share CTKB Nasdaq Global Select
Filing Documents
- d891638d8k.htm (8-K) — 21KB
- 0001193125-24-217558.txt ( ) — 136KB
- ctkb-20240909.xsd (EX-101.SCH) — 3KB
- ctkb-20240909_lab.xml (EX-101.LAB) — 17KB
- ctkb-20240909_pre.xml (EX-101.PRE) — 11KB
- d891638d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cytek Biosciences, Inc. Date: September 12, 2024 By: /s/ Wenbin Jiang Wenbin Jiang, Ph.D. President and Chief Executive Officer